• Alcohol use disorder
  • Project
  • Research & Development
  • Partners
  • About us
    • About us
    • Board of Directors
    • The Team
    • Scientific Advisers
  • News
Alcohol Use Disorder Alcohol Use Disorder
  • Alcohol use disorder
  • Project
  • Research & Development
  • Partners
  • About us
    • About us
    • Board of Directors
    • The Team
    • Scientific Advisers
  • News

Publication

Hem » Publication
0

Combined administration of varenicline and bupropion produces additive effects on accumbal dopamine and abolishes the alcohol deprivation effect in rats

Combined administration of varenicline and bupropion produces additive effects on accumbal dopamine and abolishes the alcohol deprivation effect in rats Bo Söderpalm | Klara Danielsson | Andrea [...]

READ MORE
Sobrera Pharma AB
  • Erik Dahlbergsgatan 11A
    411 26 Göteborg
  • info@sobrera.com
Latest news & publications
  • GREAT INTEREST IN THE PHASE 2 TRIAL FOR PATIENTS WITH AUD 12 oktober, 2023
  • Board of Directors update 10 augusti, 2023
  • Press release: Both primary endpoints successfully met in Phase 2 trial for patients with Alcohol Use Disorder (AUD) 27 april, 2023
  • We are pleased to welcome Eva Hägglund as Clinical Project Director 14 mars, 2023
  • New Board Member in Sobrera Pharma 11 oktober, 2022
Copyright All Rights Reserved © 2021
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search